vs
NATURES SUNSHINE PRODUCTS INC（NATR）とFIRST FINANCIAL CORP（THFF）の財務データ比較。上の社名をクリックして会社を切り替えられます
NATURES SUNSHINE PRODUCTS INCの直近四半期売上が大きい（$123.8M vs $70.5M、FIRST FINANCIAL CORPの約1.8倍）。FIRST FINANCIAL CORPの純利益率が高く（30.4% vs 3.3%、差は27.1%）。FIRST FINANCIAL CORPの前年同期比売上増加率が高い（14.1% vs 4.7%）。FIRST FINANCIAL CORPの直近四半期フリーキャッシュフローが多い（$86.4M vs $7.6M）。過去8四半期でFIRST FINANCIAL CORPの売上複合成長率が高い（20.8% vs 5.6%）
Natures Sunshine Products, Inc.（通称NSP）は、ハーブ、ビタミン、ミネラルを含む栄養補助食品やスキンケアなどのパーソナルケア製品の製造を行っています。本社はユタ州リーハイに置き、同州スパニッシュフォークに生産拠点を構えています。
ファーストアメリカン・ファイナンシャル・コーポレーションはアメリカの金融サービス企業で、不動産および住宅ローン業界向けに所有権保険と決済サービスを提供しており、関連分野で専門的なノウハウを蓄積した事業者です。
NATR vs THFF — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $123.8M | $70.5M |
| 純利益 | $4.1M | $21.5M |
| 粗利率 | 72.5% | — |
| 営業利益率 | 4.3% | 37.4% |
| 純利益率 | 3.3% | 30.4% |
| 売上前年比 | 4.7% | 14.1% |
| 純利益前年比 | 1379.4% | 32.1% |
| EPS（希薄化後） | $0.23 | $1.81 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $123.8M | $70.5M | ||
| Q3 25 | $128.3M | $65.8M | ||
| Q2 25 | $114.8M | $63.1M | ||
| Q1 25 | $113.2M | $62.5M | ||
| Q4 24 | $118.2M | $61.8M | ||
| Q3 24 | $114.6M | $58.4M | ||
| Q2 24 | $110.6M | $49.2M | ||
| Q1 24 | $111.0M | $48.4M |
| Q4 25 | $4.1M | $21.5M | ||
| Q3 25 | $5.3M | $20.8M | ||
| Q2 25 | $5.3M | $18.6M | ||
| Q1 25 | $4.7M | $18.4M | ||
| Q4 24 | $-321.0K | $16.2M | ||
| Q3 24 | $4.3M | $8.7M | ||
| Q2 24 | $1.3M | $11.4M | ||
| Q1 24 | $2.3M | $10.9M |
| Q4 25 | 72.5% | — | ||
| Q3 25 | 73.3% | — | ||
| Q2 25 | 71.7% | — | ||
| Q1 25 | 72.1% | — | ||
| Q4 24 | 72.0% | — | ||
| Q3 24 | 71.3% | — | ||
| Q2 24 | 71.4% | — | ||
| Q1 24 | 71.2% | — |
| Q4 25 | 4.3% | 37.4% | ||
| Q3 25 | 7.0% | 39.2% | ||
| Q2 25 | 3.7% | 36.2% | ||
| Q1 25 | 5.4% | 38.1% | ||
| Q4 24 | 3.8% | 32.4% | ||
| Q3 24 | 4.6% | 17.9% | ||
| Q2 24 | 5.1% | 27.6% | ||
| Q1 24 | 4.2% | 27.2% |
| Q4 25 | 3.3% | 30.4% | ||
| Q3 25 | 4.2% | 31.6% | ||
| Q2 25 | 4.6% | 29.5% | ||
| Q1 25 | 4.2% | 29.5% | ||
| Q4 24 | -0.3% | 26.3% | ||
| Q3 24 | 3.8% | 15.0% | ||
| Q2 24 | 1.2% | 23.1% | ||
| Q1 24 | 2.1% | 22.6% |
| Q4 25 | $0.23 | $1.81 | ||
| Q3 25 | $0.30 | $1.75 | ||
| Q2 25 | $0.28 | $1.57 | ||
| Q1 25 | $0.25 | $1.55 | ||
| Q4 24 | $-0.02 | $1.37 | ||
| Q3 24 | $0.23 | $0.74 | ||
| Q2 24 | $0.07 | $0.96 | ||
| Q1 24 | $0.12 | $0.93 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $93.9M | — |
| 総負債低いほど良い | — | $188.2M |
| 株主資本純資産 | $161.6M | $650.9M |
| 総資産 | $261.1M | $5.8B |
| 負債/資本比率低いほどレバレッジが低い | — | 0.29× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $93.9M | — | ||
| Q3 25 | $95.6M | — | ||
| Q2 25 | $81.3M | — | ||
| Q1 25 | $86.5M | — | ||
| Q4 24 | $84.7M | — | ||
| Q3 24 | $78.7M | — | ||
| Q2 24 | $68.7M | — | ||
| Q1 24 | $77.8M | — |
| Q4 25 | — | $188.2M | ||
| Q3 25 | — | $170.5M | ||
| Q2 25 | — | $122.7M | ||
| Q1 25 | — | $124.9M | ||
| Q4 24 | — | $28.1M | ||
| Q3 24 | — | $30.5M | ||
| Q2 24 | — | $108.6M | ||
| Q1 24 | $2.1M | $58.6M |
| Q4 25 | $161.6M | $650.9M | ||
| Q3 25 | $166.7M | $622.2M | ||
| Q2 25 | $163.7M | $587.7M | ||
| Q1 25 | $167.1M | $571.9M | ||
| Q4 24 | $161.0M | $549.0M | ||
| Q3 24 | $162.6M | $566.0M | ||
| Q2 24 | $156.4M | $530.7M | ||
| Q1 24 | $159.7M | $520.8M |
| Q4 25 | $261.1M | $5.8B | ||
| Q3 25 | $264.8M | $5.7B | ||
| Q2 25 | $254.9M | $5.6B | ||
| Q1 25 | $252.7M | $5.5B | ||
| Q4 24 | $240.9M | $5.6B | ||
| Q3 24 | $245.3M | $5.5B | ||
| Q2 24 | $235.8M | $4.9B | ||
| Q1 24 | $247.3M | $4.9B |
| Q4 25 | — | 0.29× | ||
| Q3 25 | — | 0.27× | ||
| Q2 25 | — | 0.21× | ||
| Q1 25 | — | 0.22× | ||
| Q4 24 | — | 0.05× | ||
| Q3 24 | — | 0.05× | ||
| Q2 24 | — | 0.20× | ||
| Q1 24 | 0.01× | 0.11× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $9.9M | $90.4M |
| フリーキャッシュフロー営業CF - 設備投資 | $7.6M | $86.4M |
| FCFマージンFCF / 売上 | 6.1% | 122.5% |
| 設備投資強度設備投資 / 売上 | 1.9% | 5.6% |
| キャッシュ転換率営業CF / 純利益 | 2.41× | 4.21× |
| 直近12ヶ月FCF直近4四半期 | $28.8M | $144.3M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $9.9M | $90.4M | ||
| Q3 25 | $18.5M | $26.9M | ||
| Q2 25 | $4.3M | $12.7M | ||
| Q1 25 | $2.6M | $21.1M | ||
| Q4 24 | $12.2M | $60.4M | ||
| Q3 24 | $9.6M | $23.3M | ||
| Q2 24 | $1.3M | $8.8M | ||
| Q1 24 | $2.2M | $12.4M |
| Q4 25 | $7.6M | $86.4M | ||
| Q3 25 | $16.8M | $25.8M | ||
| Q2 25 | $3.0M | $11.6M | ||
| Q1 25 | $1.5M | $20.5M | ||
| Q4 24 | $10.0M | $54.3M | ||
| Q3 24 | $7.9M | $19.5M | ||
| Q2 24 | $-2.0M | $8.4M | ||
| Q1 24 | $-1.5M | $11.5M |
| Q4 25 | 6.1% | 122.5% | ||
| Q3 25 | 13.1% | 39.2% | ||
| Q2 25 | 2.6% | 18.4% | ||
| Q1 25 | 1.3% | 32.8% | ||
| Q4 24 | 8.5% | 87.8% | ||
| Q3 24 | 6.9% | 33.5% | ||
| Q2 24 | -1.9% | 17.2% | ||
| Q1 24 | -1.4% | 23.7% |
| Q4 25 | 1.9% | 5.6% | ||
| Q3 25 | 1.3% | 1.7% | ||
| Q2 25 | 1.2% | 1.8% | ||
| Q1 25 | 1.0% | 0.9% | ||
| Q4 24 | 1.9% | 9.9% | ||
| Q3 24 | 1.5% | 6.5% | ||
| Q2 24 | 3.0% | 0.7% | ||
| Q1 24 | 3.3% | 2.0% |
| Q4 25 | 2.41× | 4.21× | ||
| Q3 25 | 3.46× | 1.29× | ||
| Q2 25 | 0.81× | 0.68× | ||
| Q1 25 | 0.55× | 1.14× | ||
| Q4 24 | — | 3.72× | ||
| Q3 24 | 2.21× | 2.67× | ||
| Q2 24 | 0.97× | 0.77× | ||
| Q1 24 | 0.94× | 1.14× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
THFF
セグメントデータなし
